| Description |
xxvi, 457 pages : illustrations ; 24 cm |
| Bibliography |
Includes bibliographical references (pages 405-422) and index. |
| Contents |
Table of contents -- Preface -- Introduction -- Part I: The Deadly World of Dangerous Medicines -- Historical Examples of Dangerous Medicines -- Understanding the Problem -- Overview of Research Findings and Possible Solutions -- Part II: Dangerous Drug Problems by Location -- Africa -- India -- China -- Middle East -- Other Emerging Markets -- The Online Drug Market -- Part III: Drug-Quality Assessments -- Factors to Consider for Research -- Results: What We Found -- Results Broken Down for Africa, India, and Other Markets -- Interpreting and Discussing the Results and Their Relevance -- Part IV: The Way Forward -- Developing Medical Regulatory Authorities: The U.S. FDA as a Case Study -- International Cooperation against Criminals and the Lethal Trade in Fake Medicines -- Market for Products of Varying Quality and the Intellectual Property Debate. |
| Subject |
Pharmaceutical industry -- Corrupt practices.
|
|
Drug adulteration.
|
|
Product counterfeiting.
|
|
Drug traffic.
|
|
Counterfeit Drugs. |
|
Fraud. |
| Added Title |
Deadly world of falsified and substandard medicines |
|
Fake : the deadly world of falsified and substandard medicines |
| ISBN |
9780844772332 (pk) |
|
084477233X (pk) |
|
